Evidence map›Paper›PMID 40005474›Full record

ReviewMedicina (Kaunas, Lithuania)2025

The Role of Artificial Intelligence in Obesity Risk Prediction and Management: Approaches, Insights, and Recommendations.

Lillian Huang, Ellen N Huhulea, Elizabeth Abraham, Raphael Bienenstock, Esewi Aifuwa, Rahim Hirani, Atara Schulhof, Raj K Tiwari, Mill Etienne

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Precision or Paradox? AI-Driven Adiposity Imaging in Women With Overweight and Obesity: A Systematic Review and Meta-Analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Artificial Intelligence in Obesity Prevention.Healthcare (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lillian HuangSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.
Ellen N HuhuleaSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0009-0001-5999-8245
Elizabeth AbrahamSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.
Raphael BienenstockSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0009-0003-5694-7789
Esewi AifuwaSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0009-0001-5523-167X
Rahim HiraniSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0000-0002-9304-9916
Atara SchulhofSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0000-0002-1617-0923
Raj K TiwariSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.
Mill EtienneSchool of Medicine, New York Medical College, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.ORCID 0000-0002-8086-3986

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Greater than 650 million individuals worldwide are categorized as obese, which is associated with significant health, economic, and social challenges. Given its overlap with leading comorbidities such as heart disease, innovative solutions are necessary to improve risk prediction and management strategies. In recent years, artificial intelligence (AI) and machine learning (ML) have emerged as powerful tools in healthcare, offering novel approaches to chronic disease prevention. This narrative review explores the role of AI/ML in obesity risk prediction and management, with a special focus on childhood obesity. We begin by examining the multifactorial nature of obesity, including genetic, behavioral, and environmental factors, and the limitations of traditional approaches to predict and treat morbidity associated obesity. Next, we analyze AI/ML techniques commonly used to predict obesity risk, particularly in minimizing childhood obesity risk. We shift to the application of AI/ML in obesity management, comparing perspectives from healthcare providers versus patients. From the provider's perspective, AI/ML tools offer real-time data from electronic medical records, wearables, and health apps to stratify patient risk, customize treatment plans, and enhance clinical decision making. From the patient's perspective, AI/ML-driven interventions offer personalized coaching and improve long-term engagement in health management. Finally, we address key limitations and challenges, such as the role of social determinants of health, in embracing the role of AI/ML in obesity management, while offering our recommendations based on our literature review.

Indexed as

Artificial IntelligenceObesityHumansMachine LearningPediatric ObesityRisk AssessmentRisk Factorsartificial intelligencechildhood obesitymachine learningobesity

Identifiers

PMID40005474
PMCPMC11857386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.